Efficient growth inhibition of HPV 16 E6-expressing cells by an adenovirus-expressing p53 homologue p73β

Oncogene

Volumn 22, Issue 52, 2003, Pages 8394-8402

  Das, Sanjeev ^a   El Deiry, Wafik S ^b   Somasundaram, Kumaravel ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cervical cancer; E6; Gene therapy; Human papilloma virus; p53; p73

Indexed keywords

ADENOVIRUS VECTOR; GENE PRODUCT; PROTEIN E6; PROTEIN P21; PROTEIN P53; PROTEIN P73; PROTEIN P73 BETA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE G1 PHASE; DNA SYNTHESIS; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; UTERINE CERVIX CANCER; VIRUS ONCOGENE; WART VIRUS;

ADENOVIRIDAE; CELL DIVISION; DNA-BINDING PROTEINS; FEMALE; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HELA CELLS; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

ADENOVIRIDAE; DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0348014550     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206908     Document Type: Article

References (37)

1. Beer-Romero P, Glass S and Rolfe M. (1997). Oncogene, 14, 595-602.
2. Blagosklonny M and El-Deiry WS. (1996). Int. J. Cancer, 67, 386-392.
3. Brinton LA. (1992). Epidemiology of Cervical Cancer - Overview: The Epidemiology of Human Papillomavirus and Cervical Cancer, Munoz N, Bosch F, Shah KV and Meheus A (eds). Oxford University Press: Oxford, pp. 3-23.
4. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B. (1998). Science, 282, 1497-1501.
5. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WD, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
6. Grenlee RT, Hill-Harmon MB, Murray T and Thun M. (2001). CA Cancer J. Clin., 51, 15-36.
7. Hamada K, Alemany R, Zhang WW, Hittelman WN, Lotan R, Roth JA and Mitchell MF. (1996). Cancer Res., 56, 3047-3054.
8. Haupt YR, Maya R, Kaza A and Oren M. (1997). Nature, 387, 296-299.
9. He TC, Zhou S, DaCosta LT, Yu J, Kinzler KW and Vogelstein B. (1998). Proc. Natl. Acad. Sci. USA, 95, 2509-2514.
10. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
11. Huh WK, Gomez-Navarro J, Arafat WO, Xiang J, Mahasreshti PJ, Alvarez RD, Barnes MN and Curiel DT. (2001). Gynecol. Oncol., 83, 370-377.
12. Jost CA, Marin MC and Kaelin WG. (1997). Nature, 389, 191-194.
13. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
14. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ. (1998). Proc. Natl. Acad. Sci. USA, 5, 8292-8297.
15. Kubbutat MGH, Jones SN and Vousden K. (1997). Nature, 387, 299-303.
16. Lechner MA and Laminis LA. (1994). J. Virol., 68, 4262-4273.
17. Levine AJ. (1997). Cell, 88, 323-331.
18. Lungu O, Sun XW, Wright TCJ, Ferenczy A, Richart RM and Silverstein S. (1995). Obstet. Gynecol., 85, 337-342.
19. Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D and Kaelin WG. (1998). Mol. Cell. Biol., 8, 6316-6324.
20. Oliner JD, Pientenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. (1993). Nature, 362, 857-860.
21. Orlow I, LaRue H, Osman I, Lacombe L, Moore L, Rabbani F, Meyer F, Fradet Y and Cordon-Cardo C. (1999). Am. J. Pathol., 155, 105-113.
22. Prabhu NS, Blagosklonny M, Zeng YX, Wu GS, Waldman T and El-Deiry WS. (1996). Clin. Cancer Res., 2, 1221-1229.
23. Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M and El-Deiry WS. (1998). Int. J. Oncol., 13, 5-9.
24. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS and Burk RD. (1997). J. Clin. Microbiol., 35, 1304-1310.
25. Rose PG and Eifel PJ. (2000). Combined Modality Treatment for Carcinoma of the Cervix: Cancer, Principles and Practice of Oncology, DeVita V, Hellman S and Rosenberg S (eds). Lippincott-Raven: Philadelphia, PA, pp. 14:1-14:10.
26. Scheffner M, Munger K, Byrne JC and Howley PM. (1991). Proc. Natl. Acad. Sci. USA, 88, 5523-5527.
27. Somasundaram K and El-Deiry WS. (1997). Oncogene, 14, 1047-1105.
28. Somasundaram K, Jayaraman G, Williams T, Moran E, Frisch S and Thimmapaya B. (1996). Proc. Nat. Acad. Sci. USA, 93, 3088-3093.
29. Somasundaram K, MacLachlan TK, Burns TF, Sgagias M, Cowan KH, Weber BL and El-Deiry WS. (1999). Oncogene, 18, 6605-6614.
30. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. (1998). EMBO J., 17, 5001-5014.
31. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G and Banks L. (1998). Nature, 393, 229-234.
32. Takimoto R, MacLachlan TK, Dicker DT, Niitsu Y, Mori T and El-Deiry WS. (2002). Can. Biol. Ther., 1, 177-186.
33. Tsao YP, Huang SG, Chang JL, Hsieh JT, Pong RC and Chen SL. (1999). J. Virol., 78, 4983-4990.
34. Wu GS and El-Deiry WS. (1996). Clin. Cancer Res., 4, 623-633.
35. Yatabe N, Kyo S, Kondo S, Kanaya T, Wang Z, Maida Y, Takakura M, Nakamura M, Tanaka M and Inoue M. (2002). Cancer Gene Ther., 9, 624-630.
36. Zeng YX, Somasundaram K and El-Deiry WS. (1997). Nat. Genet., 15, 28-32.
37. Zhang Y, Xiong Y and Yarbrough WG. (1998). Cell, 92, 725-734.